Literature DB >> 21702869

Phenotypic characterization of mononuclear blood cells from pregnant Gabonese and their newborns.

Carsten Köhler1, Ayola A Adegnika, Reinier van der Linden, Adrian J F Luty, Peter G Kremsner.   

Abstract

OBJECTIVES: As many studies have analysed the immunological phenotype of either neonatal cord or maternal blood during pregnancy, but few have compared paired maternal and neonatal samples, we designed and conducted such a study in a Central African setting.
METHODS: We used flow cytometric analyses with blood samples from pairs of Gabonese mothers and their newborns to determine the cellular composition of mononuclear cells as well as the activation status of T and B lymphocytes and antigen-presenting cells.
RESULTS: The results indicate higher activation levels of neonatal cells involved in the first-line defence against pathogens such as natural killer cells, while the neonatal T- and B-cell compartment as well as the neonatal monocyte subpopulations shows a less mature phenotype.
CONCLUSIONS: Our findings likely reflect a specific neonatal defence mechanism that compensates for otherwise poorly developed immune responses at birth, especially important in an area with a high burden of infectious agents such as Gabon. The data contribute to the establishment of reference values for the mother-neonate relationship in African regions that have similar environmental characteristics.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21702869     DOI: 10.1111/j.1365-3156.2011.02812.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  1 in total

1.  Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.

Authors:  Sami B Kanaan; Hilary S Gammill; Whitney E Harrington; Stephen C De Rosa; Philip A Stevenson; Alexandra M Forsyth; Judy Allen; Emma Cousin; Koen van Besien; Colleen S Delaney; J Lee Nelson
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.